The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disclosure re Directors' Participation in Placing

21 Jul 2020 07:00

RNS Number : 5465T
Velocys PLC
21 July 2020
 

News release

Velocys plc

("Velocys" or the "Company")

21 July 2020

Disclosure re directors' participation in the placing and open offer

 

Velocys plc (VLS.L), the sustainable fuels technology company (the "Company"), announces that, further to the announcement on 25 June 2020 advising the proposed subscription by the directors of the Company of an aggregate of 1,200,000 new ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 5p per new Ordinary Share as part of the placing, and following the subscription by certain directors of the Company for an aggregate of 96,487 new Ordinary Shares at a price of 5p per new Ordinary Share as part of the open offer announced by the Company on 24 June 2020 and 25 June 2020, the corresponding disclosure forms summarised below have today been submitted online to the FCA in relation to these transactions.

 

The resultant interests of the relevant directors and persons closely associated with them in the shares of the Company are:

 

Director

Number of Ordinary Shares held

Percentage of entire issued share capital

1. Philip Holland

1,203,118

0.11%

2. Henrik Wareborn

2,118,445

0.20%

3. Andrew Morris

847,817

0.08%

4. Sandra Shaw

551,091

0.05%

5. Darran Messem

433,333

0.04%

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Philip Holland

2. Henrik Wareborn

3. Andrew Morris

4. Cecil Shaw

5. Darran Messem

2.

Reason for the notification

a)

Position / status

1. Non-executive Chairman

2. Chief Executive Officer

3. Chief Financial Officer

4. Person closely associated with a PDMR - Sandra Shaw, Non-executive Director

5. Non-executive Director

b)

Initial notification / amendment

Initial notification

3.

Details of issuer

a)

Name

Velocys plc

b)

LEI

549300KGMQV70HA5Y715

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 1p each

 

1. GB00B11SZ269

2. GB00B11SZ269

3. GB00B11SZ269

4. GB00B11SZ269

5. GB00B11SZ269

 

b)

Nature of the transaction

Subscription for new Ordinary Shares.

The transaction is not linked to the exercise of a share option programme.

c)

Price(s) and volume(s)

Director/PCA Name

Price

Volume

1. Philip Holland

5p

230,224

2. Henrik Wareborn

5p

451,779

3. Andrew Morris

5p

414,484

4. Cecil Shaw

5p

100,000

5. Darran Messem

5p

100,000

d)

Aggregated information

Aggregated volume Price

 N/A

e)

Date of the transactions

Director/PCA Name

Date of Transaction

1. Philip Holland

2020-07-16 GMT

2. Henrik Wareborn

2020-07-16 GMT

3. Andrew Morris

2020-07-16 GMT

4. Cecil Shaw

2020-07-16 GMT

5. Darran Messem

2020-07-16 GMT

f)

Place of the transaction

Outside a trading venue

 

 

 

- Ends -

For further information, please contact:

Velocys

Henrik Wareborn, CEO

Andrew Morris, CFO

Lak Siriwardene, Head of Communications & Sustainability

 

+44 1865 800821

 

Numis Securities (Nomad and joint broker)

Stuart Skinner

Louis McKeeve

 

+44 20 7260 1000

Canaccord Genuity (Joint broker)

Henry Fitzgerald-O'Connor

James Asensio

+44 20 7523 8000

 

 

 

Turner Pope Investments (Joint broker)

James Pope

 

Radnor Capital (Investor relations)

Joshua Cryer

Iain Daly

+44 20 3657 0050

 

 

+44 20 3897 1830

 

 

Field Consulting (PR)

Robert Jeffery

 

+44 20 7096 7730

 

 

www.velocys.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHURABRRSUBUAR
Date   Source Headline
14th Mar 20237:00 amRNSAppointment of Financial Adviser
13th Mar 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSBusiness Update
25th Jan 202311:07 amRNSVelocys and Bechtel Agreement
6th Jan 20233:06 pmRNSBlock listing Interim Review
12th Dec 20227:01 amRNS£2.5m UK Government grant for new e-fuels project
12th Dec 20227:00 amRNS£27m UK Government grant for Altalto project
27th Oct 20227:00 amRNSVelocys Reference Project Improved Decarbonisation
21st Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSVelocys to participate in Barclays CEO Conference
1st Sep 20227:00 amRNSTotal Voting Rights
15th Aug 20227:00 amRNSUpdate on climate legislation
28th Jul 20227:00 amRNSAdditional Application for Block Admission
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
23rd Jun 20227:00 amRNSGrant of Share Option to Director
21st Jun 20223:01 pmRNSResults of Annual General Meeting
9th Jun 20227:00 amRNSAppointment of Chief Financial Officer
30th May 20227:00 amRNSMailing of 2021 annual report and AGM notice
23rd May 20224:31 pmRNSHolding(s) in Company
18th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20227:00 amRNSFinal Results
13th May 20229:36 amRNSInvestor Presentation
29th Apr 20227:00 amRNSNotice of Results
19th Apr 20227:00 amRNSFurther business update
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSBusiness Update and Notice of Results
1st Apr 20223:26 pmRNSNotification of Major Holdings
1st Apr 20223:21 pmRNSNotification of Major Holdings
24th Mar 20227:00 amRNSSale and purchase option agreed for Altalto site
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20221:08 pmRNSHolding(s) in Company
1st Mar 20221:04 pmRNSHolding(s) in Company
1st Mar 202212:25 pmRNSTotal Voting Rights
10th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 20224:30 pmRNSBlock listing Interim Review
23rd Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20217:00 amRNSHolding(s) in Company
20th Dec 202110:51 amRNSHolding(s) in Company
17th Dec 20218:02 amRNSExercise of Option over Altalto Project Site
17th Dec 20218:01 amRNSDirector/PDMR Dealings
15th Dec 202111:36 amRNSResults of General Meeting and Open Offer
26th Nov 20217:00 amRNSResult of Placing
25th Nov 20215:09 pmRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.